← All organizations

Highest phase reached
Phase 2
First clinical trial
Dec 1, 2013Last known activity
Jan 31, 2023
Timeline
2000s
- Jun 1, 2005
Immune System Key Ltd— Founded
Drugs by trial phase (2 distinct, 5 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05661201CollaboratorPhase 1Jan 31, 2023
- NCT04365179Lead sponsorPhase 1May 15, 2020
- NCT03634150Lead sponsorPhase 1/Phase 2Aug 20, 2018
- NCT03634150Study directorPhase 1/Phase 2Aug 20, 2018
- NCT03059615Lead sponsorPhase 2Apr 2, 2017
- NCT03059615Study directorPhase 2Apr 2, 2017
- NCT01690741Study directorPhase 1Dec 1, 2013
- NCT01690741Lead sponsorPhase 1Dec 1, 2013
Details
- Founded
- Jerusalem, IL Jun 1, 2005
- Last known activity
- Jan 31, 2023